Drugs / GRC 17536
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT01556152 Comparator | — | diabetic polyneuropathy | Glenmark Pharmaceuticals Ltd. India | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GRC 17536 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01556152 ↗ |
| Known as | ISC-17536 | ChEMBL registry synonym — accepted as the source's own label CHEMBL3707318 ↗ |
| Action | Inhibit | “Transient receptor potential cation channel subfamily A member 1 antagonist” CHEMBL3707318 ↗ |
| Target | TRPA1 | “Transient receptor potential cation channel subfamily A member 1 antagonist” CHEMBL3707318 ↗ |